We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Studies on Natural Products—Reply

Tony Chow, MD; Steven M. Green, MD
Arch Intern Med. 2006;166(3):370-371. doi:10.1001/archinte.166.3.371.
Text Size: A A A
Published online


In reply

The criticisms of Costello and Betz are not specific to our study but rather broadly apply to essentially all existing research on so-called dietary supplements derived from botanical sources. We agree that such research can be confounded by the inconsistent potency of these nonregulated preparations.1

In our article we clearly detail the brand name, manufacturer, and labeled contents of our Ginkgo biloba preparation in general accordance with the various guidelines referenced by Betz and Costello. We do not understand their criticism that we used “only 120 mg” twice daily of Ginkgo biloba because this is generally considered a “high dosage”2 and was chosen to correspond to prior similar research. Neither of the 2 other minor herbal preparations in our Ginkgo biloba product has any theoretical or experiential basis for impacting altitude-related illness. We disagree with the suggestion that our trial cannot address the study question because we selected a common brand obtained from a large chain dietary supplement store. Thus, our study readily addresses the “real-world” practicality of what a typical person can expect should they purchase over-the-counter Ginkgo biloba in hope of mitigating acute mountain sickness.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles